Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Boland

Showing results (151-160 of 203) with videos related to

Pageof 21
Sort By:
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 23, 2024
Neurosensory, cognitive and academic outcomes at 8 years in children born 22-23 weeks' gestation compared with more mature birthsIndia Rm Marks, Lex W Doyle, Rheanna M Mainzer, et al.
Health Technology Assessment (Winchester, England)|January 18, 2006
The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviewsC Black, A Bagust, A Boland, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancerN Fleeman, A Bagust, C McLeod, et al.
Health Technology Assessment (Winchester, England)|March 14, 2012
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergyJ Hockenhull, M Elremeli, M G Cherry, et al.
The Breast Journal|December 3, 2020
Lobular intraepithelial neoplasia: Outcomes and optimal managementPatrick A Boland, Emma C Dunne, Akvile Kovanaite, et al.
Health Technology Assessment (Winchester, England)|September 13, 2011
The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic reviewN Fleeman, C Martin Saborido, K Payne, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary interventionJ Greenhalgh, A Bagust, A Boland, et al.
Health Technology Assessment (Winchester, England)|July 2, 2009
Erlotinib for the treatment of relapsed non-small cell lung cancerC McLeod, A Bagust, A Boland, et al.
Angewandte Chemie (International Ed. in English)|June 19, 2024
A Fragment-Based Competitive <sup>19</sup>F LB-NMR Platform For Hotspot-Directed Ligand ProfilingWilliam J McCarthy, Sherine E Thomas, Tayo Olaleye, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancerJ Greenhalgh, C McLeod, A Bagust, et al.
Pageof 21

Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 23, 2024
Neurosensory, cognitive and academic outcomes at 8 years in children born 22-23 weeks' gestation compared with more mature birthsIndia Rm Marks, Lex W Doyle, Rheanna M Mainzer, et al.
Health Technology Assessment (Winchester, England)|January 18, 2006
The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviewsC Black, A Bagust, A Boland, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancerN Fleeman, A Bagust, C McLeod, et al.
Health Technology Assessment (Winchester, England)|March 14, 2012
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergyJ Hockenhull, M Elremeli, M G Cherry, et al.
The Breast Journal|December 3, 2020
Lobular intraepithelial neoplasia: Outcomes and optimal managementPatrick A Boland, Emma C Dunne, Akvile Kovanaite, et al.
Health Technology Assessment (Winchester, England)|September 13, 2011
The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic reviewN Fleeman, C Martin Saborido, K Payne, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary interventionJ Greenhalgh, A Bagust, A Boland, et al.
Health Technology Assessment (Winchester, England)|July 2, 2009
Erlotinib for the treatment of relapsed non-small cell lung cancerC McLeod, A Bagust, A Boland, et al.
Angewandte Chemie (International Ed. in English)|June 19, 2024
A Fragment-Based Competitive <sup>19</sup>F LB-NMR Platform For Hotspot-Directed Ligand ProfilingWilliam J McCarthy, Sherine E Thomas, Tayo Olaleye, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancerJ Greenhalgh, C McLeod, A Bagust, et al.
Pageof 21